Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

書誌詳細
主要な著者:	Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
フォーマット:	論文
言語:	English
出版事項:	Elsevier 2023-12-01
シリーズ:	Translational Oncology
主題:	Metastatic melanoma patients BRAF wild type Pembrolizumab Cytokines Monitoring Outcome predictors
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1936523323001857

類似資料

Complete response in a patient with BRAF-mutant metastatic melanoma achieved with the multidisciplinary approach: a case report
著者:: Hana Garaj, 等
出版事項: (2024-01-01)

Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
著者:: Senar Ebinç, 等
出版事項: (2023-09-01)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
著者:: Wu L, 等
出版事項: (2021-02-01)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
著者:: Katarina Mirjačić Martinović, 等
出版事項: (2023-04-01)

Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
著者:: Dugan MM, 等
出版事項: (2024-07-01)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
著者:: Polsky David, 等
出版事項: (2004-12-01)

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
著者:: Francesca Consoli, 等
出版事項: (2020-07-01)

Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study
著者:: Jacek Calik, 等
出版事項: (2024-01-01)

Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease
著者:: Xiang Dan, 等
出版事項: (2024-04-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
著者:: I. V. SAMOILENKO, 等
出版事項: (2017-06-01)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive <i>BRAF</i> Mutant Advanced Melanoma
著者:: Ernesto Rossi, 等
出版事項: (2023-01-01)

A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
著者:: Lance Wollenberg, 等
出版事項: (2023-10-01)

Potential utilization of neopterin measurements in the assessment of pyrexia in metastatic melanoma treated with combined targeted therapy: a case report
著者:: Bartoušková Marie, 等
出版事項: (2020-08-01)

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
著者:: Justin C. Moser, 等
出版事項: (2019-12-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
著者:: Yu. S. Shakh-Paronyants, 等
出版事項: (2023-03-01)

A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
著者:: Dahlia Fedele, 等
出版事項: (2024-01-01)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
著者:: Saba S. Shaikh, 等
出版事項: (2022-11-01)

Melanoma: BRAFi Rechallenge
著者:: Christoforos S. Kosmidis, 等
出版事項: (2023-05-01)

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
著者:: Milena Cavic, 等
出版事項: (2023-04-01)

MEK inhibitors for the treatment of NRAS mutant melanoma
著者:: Sarkisian S, 等
出版事項: (2018-08-01)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
著者:: Lazaro Hiram Betancourt, 等
出版事項: (2021-07-01)

Current State of Target Treatment in BRAF Mutated Melanoma
著者:: Enrica Teresa Tanda, 等
出版事項: (2020-07-01)

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report
著者:: Marco Ghezzi, 等
出版事項: (2020-03-01)

Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
著者:: Rozala Arko, 等
出版事項: (2022-07-01)

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
著者:: Ahmed Temirak, 等
出版事項: (2025-02-01)

p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
著者:: Pinakin Pandya, 等
出版事項: (2022-01-01)

Update on the treatment of BRAFmut metastatic melanoma and future perspectives
著者:: Peter Mohr, 等
出版事項: (2025-03-01)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
著者:: Karam Khaddour, 等
出版事項: (2021-06-01)

Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
著者:: Igor V. Samoylenko, 等
出版事項: (2024-10-01)

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma
著者:: Adi Kartolo, 等
出版事項: (2022-03-01)

BRAF L485–P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
著者:: Simeng Zhang, 等
出版事項: (2023-01-01)

Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report
著者:: Clara So, 等
出版事項: (2022-05-01)

Braf protein mutation and its significancy within patients with melanoma
著者:: Julia Kuchnicka, 等
出版事項: (2022-08-01)

Treatment of Advanced Melanoma: Past, Present and Future
著者:: Taku Fujimura, 等
出版事項: (2020-09-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
著者:: Elodie Long-Mira, 等
出版事項: (2022-03-01)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
著者:: Walid Shalata, 等
出版事項: (2023-02-01)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
著者:: Nakul Dar, 等
出版事項: (2023-08-01)

Tyrosine kinase inhibitors via nasogastric tube may resolve severe ileus secondary to melanoma: A case report
著者:: Lena Groennendijk, 等
出版事項: (2022-06-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
著者:: O. I. Kit, 等
出版事項: (2016-06-01)

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
著者:: Sim Vermeulen, 等
出版事項: (2021-04-01)